Douglas A Levine Selected Research

Operative Surgical Procedures

10/2010	The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
7/2003	Prophylactic surgery in hereditary breast/ovarian cancer syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas A Levine Research Topics

Disease

89	Neoplasms (Cancer) 11/2021 - 11/2003
50	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 11/2005
26	Carcinoma (Carcinomatosis) 01/2022 - 11/2003
19	Ovarian Epithelial Carcinoma 01/2019 - 04/2005
14	Endometrial Neoplasms (Endometrial Cancer) 11/2022 - 05/2002
7	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2003
4	Carcinogenesis 02/2017 - 04/2010
4	Endometrioid Carcinoma 07/2015 - 12/2012
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2013 - 04/2005
3	Small Cell Carcinoma 01/2019 - 01/2016
2	Uterine Neoplasms (Uterine Cancer) 11/2016 - 01/2016
2	Obesity 01/2016 - 02/2011
2	Ischemia 04/2015 - 07/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2011 - 12/2006
1	Testicular Neoplasms (Testicular Cancer) 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2019
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2018
1	Uterine Diseases (Endometrial Disease) 01/2018
1	Hypertension (High Blood Pressure) 12/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2017
1	Chromosomal Instability (Chromosome Stability) 07/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Anastomotic Leak 01/2016

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 11/2021 - 11/2005
14	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2007
14	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 04/2005
11	PlatinumIBA 01/2019 - 08/2007
8	MicroRNAs (MicroRNA)IBA 01/2018 - 08/2010
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 02/2008
4	Bevacizumab (Avastin)FDA Link 11/2022 - 12/2017
4	AntigensIBA 01/2020 - 07/2010
4	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2013
4	Transcription Factors (Transcription Factor)IBA 02/2017 - 02/2014
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2012
3	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 08/2013
3	Estrogen ReceptorsIBA 07/2015 - 09/2009
2	veliparibIBA 01/2022 - 06/2014
2	Formaldehyde (Formol)FDA Link 08/2021 - 05/2015
2	ParaffinIBA 08/2021 - 05/2015
2	temsirolimus FDA Link 01/2021 - 01/2018
2	ChromatinIBA 01/2019 - 01/2019
2	Vitamin D FDA LinkGeneric 01/2019 - 10/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 12/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 04/2014
2	Glycoproteins (Glycoprotein)IBA 01/2017 - 02/2007
2	ProteomeIBA 07/2016 - 07/2014
2	Genetic Markers (Genetic Marker)IBA 03/2016 - 02/2011
2	Hormones (Hormone)IBA 01/2016 - 03/2015
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2016 - 05/2014
2	Hematoxylin (Haematoxylon)IBA 01/2016 - 04/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2016 - 04/2015
2	Coloring Agents (Dyes)IBA 01/2016 - 05/2009
2	Amino Acids FDA Link 01/2015 - 06/2014
2	Phosphotransferases (Kinase)IBA 07/2014 - 04/2005
2	taxaneIBA 01/2012 - 08/2007
2	Hyaluronic Acid (Hyaluronan)IBA 11/2010 - 11/2009
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 11/2010 - 11/2009
2	OligonucleotidesIBA 11/2005 - 12/2004
1	Matrix Metalloproteinases (MMPs)IBA 11/2022
1	ORALIT (ORS)IBA 01/2021
1	DNA Polymerase IIIBA 01/2021
1	Circular RNAIBA 01/2020
1	CateninsIBA 01/2020
1	Cyclin D1IBA 01/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Troleandomycin (TAO)FDA Link 01/2018
1	Circulating Tumor DNAIBA 01/2018
1	Monomeric GTP-Binding ProteinsIBA 01/2018
1	ixabepilone (BMS 247550)FDA Link 01/2018
1	Monoclonal AntibodiesIBA 12/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017
1	1,2-oleoylphosphatidylcholine (DOPC)IBA 01/2017
1	AntibodiesIBA 01/2017
1	Transforming Growth Factor-beta Type II ReceptorIBA 10/2016
1	hydroxide ionIBA 10/2016
1	25-hydroxyvitamin DIBA 10/2016
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2016
1	E platinumIBA 01/2016
1	Death Domain ReceptorsIBA 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016

Therapy/Procedure

28	Drug Therapy (Chemotherapy) 01/2022 - 11/2005
19	Therapeutics 01/2021 - 06/2008
7	Cytoreduction Surgical Procedures 01/2019 - 11/2009
4	Hysterectomy 11/2016 - 04/2005
4	Laparotomy 11/2010 - 05/2005
3	Immunotherapy 01/2021 - 01/2018
3	Salpingo-oophorectomy 11/2018 - 11/2013
3	Neoadjuvant Therapy 01/2017 - 01/2012
3	Lymph Node Excision (Lymph Node Dissection) 01/2016 - 04/2005
3	Lasers (Laser) 07/2013 - 04/2010
2	Radiotherapy 01/2021 - 05/2002
2	Length of Stay 01/2016 - 07/2009
2	Operative Surgical Procedures 10/2010 - 07/2003
2	Cholecystectomy 10/2010 - 09/2004
2	Splenectomy 10/2010 - 09/2004
2	Pancreatectomy 10/2010 - 09/2004
2	Prophylactic Mastectomy 09/2007 - 07/2003
2	Trachelectomy 12/2006 - 04/2005
1	Ileostomy 01/2016